SEFACOR
Live / Registered — Registered — Section 8 accepted (as of 05 Sept 2025)
What this means for you
Registered since 27 Mar 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87581720
- Registration number
- 5432621
- Mark type
- Stylized text
- Filed
- 24 Aug 2017
- Published for opposition
- 09 Jan 2018
- Registered
- 27 Mar 2018
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research in the field of natural resources; Research on the subject of pharmaceuticals; Analysis for oil research; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research services; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Owner
- SEFACOR INC., Somerville, MA, US
- SEFACOR INC., Somerville, MA, US
- SEFACOR INC., Somerville, MA, US
Prosecution history
- 05 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 05 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 07 Apr 2025 — POST REGISTRATION ACTION MAILED - SEC. 8
- 07 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2024 — TEAS SECTION 8 RECEIVED
- 27 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Mar 2018 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jan 2018 — PUBLISHED FOR OPPOSITION
- 20 Dec 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Nov 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Nov 2017 — ASSIGNED TO EXAMINER
- 29 Aug 2017 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Aug 2017 — NEW APPLICATION ENTERED